LX4211 800 mg

DRUG2 trials

Sponsors

Lexicon Pharmaceuticals

Conditions

Healthy

Phase 1

Study to Define the Electrocardiogram Effects of a Single Dose of LX4211 in Healthy Subjects

CompletedNCT01913002

Lexicon PharmaceuticalsHealthy

Start: 2013-07-31Updated: 2013-10-30

Study to Determine the Safety, Tolerability and Pharmacokinetics Following Multiple Doses of LX4211 in Healthy Subjects

CompletedNCT01916850

Lexicon PharmaceuticalsHealthy

Start: 2013-08-31Updated: 2013-10-30